Trichomonas vaginalis: a review of epidemiologic, clinical and treatment issues
Top Cited Papers
Open Access
- 5 August 2015
- journal article
- review article
- Published by Springer Science and Business Media LLC in BMC Infectious Diseases
- Vol. 15 (1), 1-8
- https://doi.org/10.1186/s12879-015-1055-0
Abstract
Trichomonas vaginalis (TV) is likely the most common non-viral sexually transmitted infection (STI) in the world. It is as an important source of reproductive morbidity, a facilitator of HIV transmission and acquisition, and thus it is an important public health problem. Despite its importance in human reproductive health and HIV transmission, it is not a reportable disease and surveillance is not generally done. This is problematic since most persons infected with TV are asymptomatic. Metronidazole (MTZ) has been the treatment of choice for women for decades, and single dose has been considered the first line of therapy. However, high rates of retest positive are found among TV infected persons after single dose MTZ treatment. This has not been explained by drug resistance since in vitro resistance is only 2–5 %. Treatment failure can range from 7–10 % and even higher among HIV+ women. Treatment efficacy may be influenced by vaginal ecology. The origins of repeat positives need further explanation and better treatment options are needed.Keywords
This publication has 116 references indexed in Scilit:
- Bacterial Vaginosis and Risk for Trichomonas vaginalis Infection: A Longitudinal AnalysisSexually Transmitted Diseases, 2011
- Clinical Isolates of Trichomonas vaginalis Concurrently Infected by Strains of Up to Four Trichomonasvirus Species (Family Totiviridae)Journal of Virology, 2011
- Comparison of Aptima Trichomonas vaginalis Transcription-Mediated Amplification Assay and BD Affirm VPIII for Detection of T. vaginalis in Symptomatic Women: Performance Parameters and Epidemiological ImplicationsJournal of Clinical Microbiology, 2011
- A Randomized Treatment Trial: Single Versus 7-Day Dose of Metronidazole for The Treatment of Trichomonas Vaginalis Among HIV-Infected WomenJAIDS Journal of Acquired Immune Deficiency Syndromes, 2010
- Trichomoniasis and Other Sexually Transmitted Infections: Results From the 2001–2004 National Health and Nutrition Examination SurveysSexually Transmitted Diseases, 2009
- Trichomonosis and subsequent risk of prostate cancer in the Prostate Cancer Prevention TrialInternational Journal of Cancer, 2009
- Current Issues and Considerations Regarding Trichomoniasis and Human Immunodeficiency Virus in African-AmericansClinical Microbiology Reviews, 2009
- Urinary Symptoms in Adolescent Females: STI or UTI?Journal of Adolescent Health, 2007
- Draft Genome Sequence of the Sexually Transmitted Pathogen Trichomonas vaginalisScience, 2007
- Prevalence of Trichomonas vaginalis Isolates with Resistance to Metronidazole and TinidazoleAntimicrobial Agents and Chemotherapy, 2006